Advance your academic career, collaborate globally, and expand your network— join now !

Dr. Matthew McKenzie

Share Link

Share

Information

Dr. Matthew McKenzie is a Senior Lecturer in Biomedical Science and a member of the Institute for Physical Activity and Nutrition (IPAN) at Deakin. He undertook his PhD at St. Vincent’s Hospital, Melbourne, studying mitochondrial disease pathogenesis in mouse models of mitochondrial DNA (mtDNA) disease. This was followed by post-doctoral research at University College London investigating mitochondrial calcium handling. Dr. Matthew McKenzie returned to Australia in 2004, receiving an NHMRC Peter Doherty Fellowship and a Career Development Fellowship to investigate mitochondrial complex I biogenesis in disease at La Trobe University. In 2011, Dr. Matthew McKenzie was appointed as a Research Group Leader at the Hudson Institute of Medical Research and was awarded an ARC Future Fellowship to support his research program. Dr. Matthew McKenzie relocated his research lab to Deakin in 2018, where his current research focuses on the interactions between mitochondrial fatty acid beta-oxidation (FAO) and oxidative phosphorylation (OXPHOS) protein complexes and their importance in human disease pathology. His teaching focus at Deakin is cell biology and biochemistry, with his appointment as the Director for the Master of Biotechnology Course in 2023.

Short Biography

Dr. Matthew McKenzie is a Senior Lecturer in Biomedical Science and a member of the Institute for Physical Activity and Nutrition (IPAN) at Deakin. He undertook his PhD at St. Vincent’s Hospital, Melbourne, studying mitochondrial disease pathogenesis in mouse models of mitochondrial DNA (mtDNA) disease. This was followed by post-doctoral research at University College London investigating mitochondrial calcium handling. Dr. Matthew McKenzie returned to Australia in 2004, receiving an NHMRC Peter Doherty Fellowship and a Career Development Fellowship to investigate mitochondrial complex I biogenesis in disease at La Trobe University. In 2011, Dr. Matthew McKenzie was appointed as a Research Group Leader at the Hudson Institute of Medical Research and was awarded an ARC Future Fellowship to support his research program. Dr. Matthew McKenzie relocated his research lab to Deakin in 2018, where his current research focuses on the interactions between mitochondrial fatty acid beta-oxidation (FAO) and oxidative phosphorylation (OXPHOS) protein complexes and their importance in human disease pathology. His teaching focus at Deakin is cell biology and biochemistry, with his appointment as the Director for the Master of Biotechnology Course in 2023.